Related by context. All words. (Click for frequent words.) 70 NRTI resistance 69 K#N 68 HBeAg negative 68 genotypic resistance 67 mutated K ras 67 vinca alkaloid 67 ceftazidime 67 NNRTI resistant virus 67 recurrent glioblastoma multiforme 66 virus HBV 66 Lymphocytic 66 replicon 66 immunocompetent 66 Gleevec resistant 65 transgenic rats 65 caspofungin 65 enterococcal 65 relapsed MM 65 hypereosinophilic syndrome 65 papillary renal cell carcinoma 65 enteroviral 65 NNRTI resistance 65 antiretroviral naïve 65 receptor inhibitor 65 AZT zidovudine Retrovir 65 SSc 65 K#R [002] 65 cytopathic 65 resistant isolates 65 K ras mutations 64 R5 tropic 64 valent pneumococcal 64 N. gonorrhoeae 64 Pharmacokinetics PK 64 combination antiretroviral therapy 64 Akt inhibitor 64 KRAS oncogene 64 CYT# potent vascular disrupting 64 metastatic malignant 64 rifamycins 64 HIV HCV coinfected 64 protease inhibitor PI 64 gastrointestinal stromal tumors GISTs 64 fluconazole resistant 64 pyrimethamine 64 Epstein Barr Virus EBV 64 gonococcal 64 BCR ABL mutations 64 demonstrated antitumor activity 64 metastatic neuroendocrine tumors 64 refractory Hodgkin 64 castrate resistant 64 HBeAg positive 64 ano genital warts 64 murine leukemia virus 64 LHRH receptor positive 64 sJIA 64 genital ulcer 64 BRSV 64 selective modulator 64 potent inducer 64 FUSILEV enhances 64 allogeneic HSCT 64 haematopoietic 64 chlamydial 64 polymicrobial 63 ABCB1 63 S. suis 63 immune modulating 63 clade B 63 BRAF V#E mutation 63 Cytomegalovirus CMV 63 immunopathology 63 Leydig cell 63 kidney urologic 63 HBsAg 63 microsatellite instability 63 seropositivity 63 chronic eosinophilic leukemia 63 MYH9 gene 63 H. influenzae 63 discontinued Viread 63 M#V 63 Candida infection 63 prostate carcinoma 63 HIV seropositive 63 subcutaneous immunoglobulin 63 adefovir dipivoxil 63 anthracycline containing 63 oseltamivir resistant 63 lupus anticoagulant 63 Leukemias 63 varicella zoster virus VZV 63 potent cytotoxic 63 ALT normalization 63 pharmacokinetic interactions 63 lenalidomide dexamethasone 63 refractory chronic lymphocytic 63 MenACWY 63 relapsed ALL 63 darunavir r 63 nucleoside analogues 63 nonalcoholic steatohepatitis NASH 63 hemorrhagic cystitis 63 clinically evaluable 63 ribavirin RBV 63 HER2 overexpression 63 amisulpride 63 haematologic 63 abacavir Ziagen 63 Ribavirin causes 63 ADAMTS# 63 Pegylated Interferon 63 tissue transglutaminase 63 cancer mCRC 63 NMIBC 63 H#Y 63 aneuploid 63 BRAF V#E 63 nonnucleoside reverse transcriptase inhibitors 63 leukemia AML 63 alkylating agent 62 tipranavir ritonavir 62 cisplatin resistant 62 miglustat 62 artemisinin derivative 62 HepC 62 Candida glabrata 62 TTR gene 62 HBV genotype 62 Pegylated 62 trivalent influenza vaccine 62 HIV coinfected 62 HLA DR2 62 imatinib resistant 62 amphotericin 62 ara C 62 thymidine kinase 62 Babesia 62 adenoviral 62 seronegative 62 pertussis toxin 62 Immunotherapeutic 62 novel VDA molecule 62 Pegylated interferon 62 herpesviruses 62 Epstein Barr virus EBV 62 PROSTVAC VF 62 gastric carcinogenesis 62 gastric adenocarcinoma 62 cytostatic 62 erlotinib Tarceva ® 62 viremic 62 daily subcutaneous injections 62 3TC lamivudine Epivir 62 myelodysplastic myeloproliferative diseases 62 null responder 62 HBeAg 62 syngeneic 62 CCR5 tropic 62 alefacept 62 IgM antibodies 62 NRTI backbone 62 Kinoid 62 radezolid 62 microbiologically evaluable 62 atypical hemolytic uremic syndrome 62 outer membrane proteins 62 methicillin susceptible Staphylococcus aureus 62 flavopiridol 62 RhuDex ® 62 C. trachomatis 62 T#I [002] 62 imatinib therapy 62 imexon 62 complement inhibitor eculizumab 62 chronic myeloid 62 lymphomas leukemias 62 Chronic Prostatitis 62 Haptoglobin 62 M#V mutation 62 K ras gene 62 prostate cancer CaP 62 abacavir lamivudine 62 HCD# [002] 62 UGT#A# 62 highly pathogenic influenza 62 HLA DRB1 * 62 HLA DR4 immune 62 recurrent metastatic 62 recombinant hepatitis B 62 glycosylated 62 Thiovir 62 imatinib resistance 62 stavudine d4T 62 MLH1 62 tenofovir emtricitabine 62 HepG2 cells 62 coagulase negative staphylococci 62 antibody MAb 62 d4T stavudine Zerit 62 recombinant interferon 62 SPRYCEL ® 61 histologies 61 indinavir 61 C#Y 61 Adenoviral 61 nutlin 3a 61 chronic HBV 61 pneumocystis carinii pneumonia 61 mda 7 61 quasispecies 61 alkylating 61 Interferon Beta 61 adeno associated viruses 61 HCV infected 61 MVA MUC1 IL2 61 Virologic 61 parasitemia 61 dual tropic 61 antimicrobial susceptibility 61 arteritis 61 urate oxidase 61 pentostatin 61 colorectal carcinoma 61 c KIT 61 Amino acid 61 antiretroviral naive 61 nucleoside analog 61 PTPN# 61 Hepatitis B Virus 61 tumor lysate 61 chimeric monoclonal antibody 61 rifabutin 61 Antitumor 61 transgenic mouse models 61 ritonavir boosted 61 NS#/#A protease 61 GHRH 61 VP# [004] 61 HER2 neu 61 pediatric acute lymphoblastic 61 adipogenic 61 alpha2 61 germline mutations 61 COL#A# 61 cisplatin gemcitabine 61 calcineurin inhibitor 61 non nucleoside inhibitor 61 ChronVac C 61 Cytomegalovirus 61 clinicopathological 61 inactivated influenza 61 adjuvant cisplatin 61 PON1 gene 61 carcinoids 61 hepatoma 61 BRCA1 BRCA2 61 poliovirus vaccine 61 thalidomide Thalomid 61 nucleotide analogue 61 potently inhibited 61 meropenem 61 abnormal cytology 61 nucleoside 61 mutations conferring 61 XL# inhibits 61 presymptomatic 61 monoclonal anti 61 immunomodulatory therapy 61 Enterobacter cloacae 61 extrapulmonary 61 bladder carcinoma 61 unmutated 61 ritonavir boosted protease inhibitor 61 hypermethylated 61 ABSSSI 61 T1c 61 cefotaxime 61 genotype 1b 61 multidrug 61 nasal carriage 61 metastatic gastric 61 pyrazinamide 61 Plasmodium ovale 61 Vaxfectin TM formulated 61 serologic 61 cranial irradiation 61 H pylori 61 Gag polymorphisms 61 HIV uninfected 61 Rimantadine 61 cMET 61 obligate intracellular 61 HLA A2 61 inducible nitric oxide synthase 61 L. pneumophila 61 Tyrosine Kinase Inhibitor 61 linezolid resistant 61 murine models 61 HER2/neu 61 evaluating tivozanib 61 Chlamydia trachomatis 61 orally administered inhibitor 61 concomitantly administered 61 colorectal adenoma 61 tropism testing 61 gene rearrangements 61 plasma pharmacokinetics 61 immunotoxin 61 sodium stibogluconate 61 interferon induced 61 pathophysiological effects 61 seropositive patients 61 NS5b 61 UGT#A# * 61 nonmetastatic 61 DEB# 61 DermaVir 61 metastatic GIST 61 biliary tract cancer 61 tumorigenicity 61 myeloproliferative 61 metastatic malignant melanoma 61 macrolide antibiotic 61 Virulizin ® 61 idarubicin 61 #q# deletion syndrome 61 BEXXAR Therapeutic Regimen 61 LRAT 61 replicase 61 canakinumab 61 hepatocellular carcinomas 61 FLT3 mutations 61 RRM1 61 Albuferon TM 61 fluoroquinolone resistant 61 motor neuron degeneration 61 nucleotide analogs 61 Immunohistochemical analysis 61 nevirapine Viramune 61 antifolates 61 colon carcinoma 61 euthyroid 61 HBV vaccine 61 Vidaza ® 61 follicular lymphoma FL 61 toxoids 61 deletion 5q 61 P. falciparum malaria 61 FLT3 61 selectively inhibited 61 receptor blocker 61 Treg cell 60 immunomodulation 60 CML CP 60 TTR amyloidosis 60 thyroid carcinoma 60 galiximab 60 potent antiretroviral therapy 60 splenocytes 60 GH deficiency 60 IMiDs ® compound 60 bioscavenger 60 lymphoid tumors 60 Multimeric 60 pegylated 60 alfa 2a 60 induces antibodies 60 herpes zoster shingles 60 Cytotoxic 60 CCR5 antagonist 60 BMPR2 60 humoral responses 60 Chlamydia psittaci 60 Oncolytic 60 FUS1 60 epithelial tumors 60 lymphoid cells 60 weekly subcutaneous injections 60 Adrenergic 60 mitoxantrone chemotherapy 60 EGFR HER2 60 resistant mutants 60 fosbretabulin 60 patients coinfected 60 CIMZIA TM certolizumab pegol 60 cardiotoxic 60 metaplasia 60 ChronVac C R 60 S aureus 60 serogroup B 60 Inactivated 60 HCV replicon 60 bronchoalveolar lavage 60 experimental allergic encephalomyelitis 60 HLA DQ2 60 chemo immunotherapy 60 cystic fibrosis chronic pancreatitis 60 nontuberculous mycobacteria 60 CYP#D# gene 60 cytomegalovirus infection 60 antiandrogen 60 vidofludimus 60 adriamycin 60 HIV coinfection 60 JAK2 V#F 60 histone deacetylase inhibitor 60 Ph + acute lymphoblastic 60 glycopeptide 60 p# inhibitor 60 demethylating agent 60 TNF blocker therapy 60 anagrelide 60 griseofulvin 60 ELISPOT assay 60 decompensated liver disease 60 NOD mouse 60 Pegasys ® 60 potent stimulator 60 JAK2 inhibitor 60 pentamidine 60 somatostatin 60 thrombopoietin TPO natural 60 microbiologic 60 rubella hepatitis 60 neuroblastoma tumors 60 NPM1 60 CYT# QbG# 60 ganciclovir 60 PEG IFN 60 viral antigen 60 EGFR TKI 60 HLA DR4 60 clevidipine 60 thrombin receptor 60 NMDA antagonists 60 gastric carcinoma 60 nonvaccine 60 relapsed leukemia 60 Tasigna prolongs 60 tryptase 60 estramustine 60 gonorrhoeae 60 intravenous iv 60 administered intramuscularly 60 polysaccharide vaccines 60 pathogenic viruses 60 Enterococcus faecium 60 porcine derived 60 interferon IFN 60 zidovudine AZT 60 potently inhibit 60 HCV Hepatitis C 60 V#F mutation 60 γ secretase 60 CLL SLL 60 gastric carcinomas 60 hA# 60 CC genotype 60 indinavir Crixivan 60 lymphoproliferative disease 60 leukemic 60 serologic testing 60 erythropoietic 60 TDF FTC 60 Orally administered 60 gemcitabine Gemzar ® 60 essential thrombocythemia ET 60 P aeruginosa 60 Daptomycin 60 beta lactams 60 BCR ABL1 60 mutated KRAS gene 60 thymic 60 TRAIL induced apoptosis 60 e antigen HBeAg 60 tiuxetan 60 lymphocytic 60 reverse transcriptase inhibitors 60 Upregulation 60 oesophageal adenocarcinoma 60 #S rRNA gene 60 completely resected 60 sargramostim 60 Elotuzumab 60 Staphylococcus epidermidis 60 Klebsiella pneumonia 60 heterologous 60 pT2 60 hepatic enzyme 60 BCG vaccinated 60 Letairis ambrisentan 60 anthracycline chemotherapy 60 candidemia 60 scintigraphic 60 methylenetetrahydrofolate reductase 60 undetectable HBV DNA 60 heavily pretreated 60 AMACR 60 micafungin 60 serum antibody 60 treatment naive genotype 60 Recurrent Glioblastoma 60 antiangiogenic agent 60 beta lactam antibiotic 60 induced tumor regression 60 MYLOTARG 60 intraperitoneally 60 nucleoside nucleotide 60 peritoneal carcinomatosis 60 cyclophosphamide methotrexate 60 Xanafide 60 adeno 60 humanised monoclonal antibody 60 lymphoid malignancies 60 atovaquone 60 Nilotinib 60 acute respiratory tract infections 60 idiopathic myelofibrosis 60 orthopoxvirus 60 subcutaneously administered 60 Phenotypic 60 myeloablative 60 recombinant adeno associated 60 antibody titer 60 Triapine R 60 assay detects 60 postexposure 60 chronic HBV infection 60 tumoral 60 asplenia 60 Bacille Calmette Guérin BCG 60 IgG4 60 interferon ribavirin 60 fluoroquinolone resistance 60 Selective Inhibitor 60 Anaplasma 60 saline placebo 60 G CSFs 60 humanized antibody 60 diphtheria pertussis whooping cough 60 Neisseria gonorrhoeae 60 mycosis fungoides 60 GVAX ® 60 Gilead Viread 60 Saccharomyces boulardii 60 thrombocytopenic 60 pancreatic endocrine 60 eIF4E 60 eosinophilic asthma 60 hypoxia inducible factor 60 BCR ABL inhibitor 60 B. cepacia 60 COPEGUS R 60 invasive candidiasis 60 acute GvHD 60 missense mutations 60 Temsirolimus 60 NEUGENE 60 cetuximab Erbitux ® 60 quinacrine 60 myeloid 60 soluble tumor necrosis 60 Candida species 60 fusidic acid 60 histologic subtype 60 E. faecalis 60 T#I mutant 60 ergot alkaloids 60 Myelodysplastic Syndrome MDS 60 generation purine nucleoside 60 KRAS mutant 60 tenofovir Viread 60 humanized monoclonal 60 missense 60 virally induced 59 FluCAM arm 59 colorectal liver metastases 59 Enzastaurin 59 protease inhibitors PIs 59 administered subcutaneously 59 doxorubicin cyclophosphamide 59 PEGylated 59 bortezomib Velcade 59 non nucleoside 59 lesional 59 non mutated KRAS 59 pegylated liposomal doxorubicin 59 Heterozygous 59 tigecycline 59 HbF 59 piperacillin tazobactam 59 interferon alfa 2b 59 taxane resistant 59 inhibit replication 59 Valortim ® 59 corticosteroid therapy 59 transcriptase inhibitors NNRTIs 59 certolizumab 59 anti CD3 59 relapsing remitting MS RRMS 59 G6PD deficiency 59 CHOP chemotherapy 59 ethambutol 59 nelfinavir Viracept 59 im peramivir 59 Platinol ® cisplatin 59 experimentally infected 59 Leydig cells 59 subtyped 59 oral prodrug 59 nanoviricides ® 59 MAGE A3 ASCI 59 monophasic 59 methicillin sensitive 59 liver metastasis 59 polyclonal 59 Soft Tissue Sarcoma 59 autologous transplants 59 PEGylated interferon 59 CsA 59 TMPRSS2 ERG fusion 59 PIK3CA 59 K RAS 59 ActA 59 Sustiva efavirenz 59 enkephalin 59 C#BL 6 mice 59 invasive aspergillosis 59 torsade de pointes 59 Nebulized 59 torezolid 59 genotype 1a 59 antitumour 59 VSV G 59 Adjuvanted 59 genotypic 59 BARACLUDE ® 59 pegylated interferon alpha 59 coinfected 59 Varicella zoster virus 59 neural stem 59 apolipoprotein E4 59 receptor tyrosine kinase inhibitor 59 EGFR mutation positive 59 S. aureus isolates 59 protein tyrosine phosphatase 1B 59 Darinaparsin 59 pulmonary metastasis 59 Isentress raltegravir 59 clinico pathological 59 probiotic Lactobacillus 59 siRNA knockdown 59 hematopoietic cancers 59 prion strains 59 Genotypic 59 sero positive 59 transgene expression 59 suppressive therapy 59 glioblastoma tumor 59 ESBL producing 59 cytidine 59 allogeneic bone marrow 59 Aplidin R 59 Polymorphism 59 prolonged QT interval 59 retroviral 59 EGFR receptor 59 Enterobacteriaceae 59 Macrolide 59 NOD SCID mice 59 pegylated interferon alfa 2a 59 riociguat 59 JAK2 enzyme 59 Respiratory Virus 59 Hodgkin lymphoma HL 59 Saquinavir 59 Chlamydia pneumoniae 59 VZV 59 serologically 59 adenylate cyclase 59 HER2 expression 59 extramedullary 59 EBV infection 59 prospectively enrolled 59 itraconazole Sporanox 59 de novo AML 59 vWF 59 preferentially bind 59 immunodeficient 59 vivax 59 hepatitis B infection 59 specific CD8 + 59 T. vaginalis 59 plasmid encoding 59 ® lenalidomide 59 neoplasias 59 Oropharyngeal Candidiasis 59 SGPT 59 M. genitalium 59 cytomegalovirus retinitis 59 small lymphocytic lymphoma 59 docetaxel Taxotere ® 59 hENT1 59 Pneumocystis carinii pneumonia 59 CYP#A# CYP#D# 59 Mycobacterium tuberculosis MTB 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 KIT mutations 59 Respiratory Syncytial Virus RSV 59 flutamide 59 latent tuberculosis infection 59 #q# deletion 59 interleukin 1ß 59 bronchoalveolar 59 5alpha reductase 59 Prolastin A1PI 59 Naive Patients 59 chemokine receptor 59 experimental autoimmune encephalomyelitis 59 follicular thyroid cancer 59 staphylococci 59 cytotoxic T lymphocyte 59 antithymocyte globulin 59 trastuzumab Herceptin ® 59 viraemia 59 Panzem R NCD 59 primary hyperparathyroidism 59 myelofibrosis polycythemia vera 59 hemolytic 59 Decitabine 59 Bcr Abl mutations 59 GSTT1 59 aT cell 59 voriconazole 59 Allogeneic 59 supernatants 59 vinorelbine tartrate 59 heparanase 59 S. pyogenes 59 IL#B 59 Recombinant Human 59 refractory acute myeloid 59 allogeneic hematopoietic stem cell 59 Aurora Kinase 59 HDACi 59 Squamous 59 highly immunogenic 59 PKC# 59 pamidronate 59 antiphospholipid antibodies 59 HBeAg + 59 paclitaxel cisplatin 59 renal allograft 59 ertapenem 59 karyotypes 59 virus HCV 59 benzimidazole 59 conjugate vaccines 59 polycythemia vera essential thrombocythemia 59 antiandrogens 59 recurrent glioblastoma 59 serogroup 59 TransVax ™ 59 hematological parameters 59 antineoplastic 59 oblimersen 59 TNF Tumor Necrosis Factor 59 immune dysregulation 59 Valortim R 59 microtubule inhibitor 59 VIRAMUNE R 59 human IgG1 monoclonal 59 GABHS 59 FK# 59 immunized mice 59 cytotoxic effects 59 p# biomarker 59 immune globulin intravenous 59 capsular polysaccharide 59 oropharyngeal candidiasis OPC 59 cidofovir 59 hepatitis C HCV 59 antituberculosis 59 mediated inhibition 59 pretransplant 59 transarterial 59 TroVax ® 59 Vidaza azacitidine 59 NS3 protease 59 sulfamethoxazole 59 haematological malignancies 59 inverse agonist 59 cat dander allergy 59 hepatic fibrosis 59 Adefovir 59 NXL# 59 acromegalic patients 59 antimitotic 59 Onalta TM 59 interleukin IL -# 59 Streptococcus pyogenes 59 Histologic 59 KIF6 gene 59 hypogonadotropic hypogonadism 59 immunomodulatory properties 59 HBV HCV 59 lenalidomide Revlimid R 59 simplex virus 59 CD8 + cytotoxic 59 CYP #D# 59 Triapine 59 malignant lymphomas 59 neoplastic 59 metastatic pancreatic 59 glutamic acid decarboxylase 59 recurrent genital herpes 59 administered concomitantly 59 HCV polymerase 59 baseline LDH 59 AZT 3TC 59 anti CD3 antibody 59 Li Fraumeni 59 de novo kidney transplant 59 fibrosarcoma 59 Trichophyton rubrum 59 osteosarcomas 59 Sanofi Pasteur Fluzone 59 Entamoeba histolytica 59 mRCC 59 HGS ETR1 mapatumumab 59 treatment naïve genotype 59 zoledronate 59 vancomycin resistant 59 PDGF receptor 59 avosentan 59 infected macrophages 59 bevacizumab Avastin R 59 Aplidin 59 MVA BN ® 59 nonhereditary 59 leukemia CLL 59 tenofovir DF 59 included exfoliative dermatitis 59 doxorubicin Adriamycin 59 unconjugated 59 mutated KRAS 59 bovine thrombin 59 pulmonary hypertension PH 59 selectively binds 59 hemagglutination inhibition HAI 59 kidney allograft 59 cellular prion protein 59 Alequel 59 rFSH 59 PENNVAX B 59 forodesine 59 cutaneous T 59 Omacetaxine 59 gemcitabine carboplatin 58 cefixime 58 neuroendocrine cancers 58 Cefazolin 58 thyroid peroxidase 58 Leukine ® 58 NNRTIs 58 beta actin 58 somatostatin analogue 58 mitochondrial toxicity 58 Relapsing remitting MS 58 antiangiogenesis 58 nevirapine NVP 58 Associated Diarrhea 58 tetracycline antibiotic 58 CDK4 58 hMG 58 Mutational 58 human immunodeficiency 58 Linezolid 58 neutralizing antibody 58 immunocompetent patients 58 maternally inherited 58 PEGPH# 58 XOMA 3AB 58 pDC 58 basal cell carcinoma BCC 58 rhITF 58 bexarotene 58 endocrine therapies 58 latent tuberculosis TB 58 Eraxis 58 quinolone antibiotic 58 Amgen Neulasta R 58 investigational integrase inhibitor 58 Immunohistochemical 58 Protein Kinase C 58 severe oral mucositis 58 Alferon LDO 58 Clusterin 58 PBMCs 58 SCIg 58 normal karyotype 58 immune globulins 58 Cardiotoxicity 58 multicentric 58 potent antiproliferative 58 Enterobacter 58 Fingolimod 58 heterozygotes 58 denileukin diftitox 58 IgG antibody 58 imatinib Gleevec 58 Lactobacillus GG 58 splice variants 58 antinuclear antibodies 58 dasatinib Sprycel 58 bacillus Calmette Guerin BCG 58 grade squamous intraepithelial 58 Infectivity 58 Cytogenetic 58 HQK 58 catheter occlusion 58 CDKN2A 58 Cloretazine 58 systemic ALCL 58 Tyrosine Kinase Inhibitors 58 Poliovirus 58 CTEPH 58 protein tyrosine phosphatase 58 PTEN gene 58 paramyxoviruses 58 irinotecan oxaliplatin 58 isoenzyme 58 lamivudine zidovudine 58 fosamprenavir 58 MMR Measles Mumps Rubella 58 parthenolide 58 Genetic susceptibility 58 pharmacologically active isomer 58 calcineurin inhibitors 58 Kahalalide F 58 leiomyomas 58 intravenous immunoglobulin 58 RhuDex R 58 MSH2 58 cilengitide 58 immunoconjugate 58 HBV infection 58 ELISPOT 58 Bacillus Calmette Guerin BCG 58 florbetaben 58 TNF alpha selectively neutralizing 58 smoldering multiple myeloma 58 leukemic stem cells 58 acid phosphatase PAP 58 atazanavir Reyataz 58 demyelinating 58 constitutively expressed 58 Bcr Abl T#I mutation 58 HER2 amplification 58 Viread tenofovir disoproxil fumarate 58 Dendritic Cells 58 Janus kinase 58 LC#m# vaccine 58 gastrointestinal stromal tumors GIST 58 BALB c mice 58 aripiprazole Abilify 58 refractory chronic myeloid 58 peptide antigens 58 null responder HCV 58 prostate adenocarcinoma 58 reactogenicity 58 Intravenous immunoglobulin 58 HIV reverse transcriptase 58 Progressive Multifocal Leukoencephalopathy 58 skeletal metastases 58 potent suppressor 58 Haemophilus 58 ZEBOV 58 TO AVOID PREGNANCY WHILE 58 Tarceva TM 58 immunoglobulin G 58 ERBB2 58 HCV genotypes 58 cetuximab Erbitux R 58 noscapine 58 PON1 58 MYCAMINE 58 Trichomonas vaginalis 58 Interferon alpha 58 LPA gene 58 radiolabeled TM# 58 heterozygote 58 P. falciparum parasites 58 purified inactivated 58 CG# [003] 58 AKT inhibitor 58 BI/NAP#/#